Beta-defensins: What are they REALLY doing in the oral cavity?

Oral Diseases

Volumn 17, Issue 7, 2011, Pages 628-635

  Diamond, Gill ^a   Ryan, L K ^b  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Antimicrobial peptide; Defensin; Innate immunity; Oral cancer

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; BETA DEFENSIN 5; CYTOKINE;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; CELL PROLIFERATION; CHEMOTAXIS; CYTOKINE RELEASE; GINGIVAL BIOPSY; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; MICROORGANISM; MOUTH CAVITY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; WOUND HEALING;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CHEMOTACTIC FACTORS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MICROBIAL INTERACTIONS; MOUTH; NEOPLASMS;

EID: 80051552897     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01799.x     Document Type: Review

References (95)

1. Abiko Y, Mitamura J, Nishimura M et al (1999). Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett 143: 37-43.
2. Allavena P, Sica A, Garlanda C, Mantovani A (2008). The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 222: 155-161.
3. Baroni A, Donnarumma G, Paoletti I et al (2009). Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells. Peptides 30: 267-272.
4. Beckloff N, Diamond G (2008). Computational analysis suggests beta-defensins are processed to mature peptides by signal peptidase. Protein Peptide Lett 15: 536-540.
5. Biragyn A, Surenhu M, Yang D et al (2001). Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J Immunol 167: 6644-6653.
6. Biragyn A, Ruffini PA, Leifer CA et al (2002). Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298: 1025-1029.
7. Brissette CA, Lukehart SA (2002). Treponema denticola is resistant to human beta-defensins. Infect Immun 70: 3982-3984.
8. Brissette CA, Pham TT, Coats SR, Darveau RP, Lukehart SA (2008). Treponema denticola does not induce production of common innate immune mediators from primary gingival epithelial cells. Oral Microbiol Immunol 23: 474-481.
9. Brogden KA, Heidari M, Sacco RE et al (2003). Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol 18: 95-99.
10. Chen X, Niyonsaba F, Ushio H et al (2007). Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur J Immunol 37: 434-444.
11. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM (2001). Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. J Immunol 167: 623-627.
12. Conti HR, Shen F, Nayyar N et al (2009). Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206: 299-311.
13. Devine DA, Marsh PD, Percival RS, Rangarajan M, Curtis MA (1999). Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp. Microbiology 145(Pt 4): 965-971.
14. Diamond G, Zasloff M, Eck H, Brasseur M, Maloy WL, Bevins CL (1991). Tracheal antimicrobial peptide, a novel cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci (USA) 88: 3952-3956.
15. Diamond G, Kaiser V, Rhodes J, Russell JP, Bevins CL (2000). Transcriptional regulation of β-defensin gene expression in tracheal epithelial cells. Infect Immun 68: 113-119.
16. Diamond G, Laube D, Klein-Patel ME (2004). Mammalian b-defensins in mucosal defences. In: Hancock REW, Devine DA, eds. Mammalian Host Defence Peptides. Cambridge University Press: Cambridge, UK, pp. 111-138.
17. Diamond G, Beckloff N, Ryan LK (2008). Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res 87: 915-927.
18. Diamond G, Beckloff N, Weinberg A, Kisich KO (2009). The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 15: 2377-2392.
19. Dietrich DE, Xiao X, Dawson DV et al (2008). Human alpha- and beta-defensins bind to immobilized adhesins from Porphyromonas gingivalis. Infect Immun 76: 5714-5720.
20. van Dijk A, Veldhuizen EJ, Haagsman HP (2008). Avian defensins. Vet Immunol Immunopathol 124: 1-18.
21. Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH (2002). Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology 106: 517-525.
22. Feng Z, Jiang B, Chandra J, Ghannoum M, Nelson S, Weinberg A (2005). Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res 84: 445-450.
23. Feng Z, Dubyak GR, Lederman MM, Weinberg A (2006). Cutting edge: human beta defensin 3 - a novel antagonist of the HIV-1 coreceptor CXCR4. J Immunol 177: 782-786.
24. Funderburg N, Lederman MM, Feng Z et al (2007). Human defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci (USA) 104: 18631-18635.
25. Ganz T, Liu L, Valore EV, Oren A (1993). Posttranslational processing and targeting of transgenic human defensin in murine granulocyte, macrophage, fibroblast, and pituitary adenoma cell lines. Blood 82: 641-650.
26. Harwig SSL, Park ASK, Lehrer RI (1992). Characterization of defensin precursors in mature human neutrophils. Blood 79: 1532-1537.
27. Ji S, Hyun J, Park E, Lee BL, Kim KK, Choi Y (2007). Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J Periodontal Res 42: 410-419.
28. Ji S, Shin JE, Kim YC, Choi Y (2010). Intracellular degradation of Fusobacterium nucleatum in human gingival epithelial cells. Molecules and Cells. DOI:10.1007/s10059-010-0142-8.
29. Jin G, Kawsar HI, Hirsch SA et al (2010). An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS ONE 5: e10993.
30. Johnston A, Gudjonsson JE, Aphale A et al (2010). Signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner. J Invest Dermatol 131: 329-337.
31. Joly S, Maze C, McCray PB Jr, Guthmiller JM (2004). Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42: 1024-1029.
32. Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM (2009). Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol 24: 353-360.
33. Jones DE, Bevins CL (1992). Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 267: 23216-23225.
34. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA (2003). Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 41: 90-96.
35. Kawsar HI, Weinberg A, Hirsch SA et al (2009). Overexpression of human beta-defensin-3 in oral dysplasia: potential role in macrophage trafficking. Oral Oncol 45: 696-702.
36. Kawsar HI, Ghosh SK, Hirsch SA, Koon HB, Weinberg A, Jin G (2010). Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor beta. Peptides 31: 195-201.
37. Kesting MR, Loeffelbein DJ, Hasler RJ et al (2009). Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest 27: 575-581.
38. Kohlgraf KG, Ackermann A, Lu X et al (2010a). Defensins attenuate cytokine responses yet enhance antibody responses to Porphyromonas gingivalis adhesins in mice. Future Microbiol 5: 115-125.
39. Kohlgraf KG, Pingel LC, Dietrich DE, Brogden KA (2010b). Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol 5: 99-113.
40. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA (2000). Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier [In process citation]. Infect Immun 68: 2907-2915.
41. Kurland AR, Schreiner H, Diamond G (2006). In vivoβ-defensin gene expression in rat gingival epithelium in response to Actinobacillus actinomycetemcomitans infection. J Periodontal Res 41: 567-572.
42. Lu Q, Jin L, Darveau RP, Samaranayake LP (2004). Expression of human beta-defensins-1 and -2 peptides in unresolved chronic periodontitis. J Periodontal Res 39: 221-227.
43. Mizukawa N, Sawaki K, Nagatsuka H et al (2001). Human alpha-and beta-defensin immunoreactivity in oral mucoepidermoid carcinomas. Anticancer Res 21: 2171-2174.
44. Morrison G, Kilanowski F, Davidson D, Dorin J (2002). Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun 70: 3053-3060.
45. Moser C, Weiner DJ, Lysenko E, Bals R, Weiser JN, Wilson JM (2002). beta-defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 70: 3068-3072.
46. Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I (2001). Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol 31: 1066-1075.
47. Niyonsaba F, Iwabuchi K, Matsuda H, Ogawa H, Nagaoka I (2002). Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol 14: 421-426.
48. Niyonsaba F, Ogawa H, Nagaoka I (2004). Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111: 273-281.
49. Niyonsaba F, Ushio H, Nakano N et al (2007). Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127: 594-604.
50. Niyonsaba F, Ushio H, Hara M et al (2010). Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells. J Immunol 184: 3526-3534.
51. Offenbacher S, Barros SP, Paquette DW et al (2009). Gingival transcriptome patterns during induction and resolution of experimental gingivitis in humans. J Periodontol 80: 1963-1982.
52. Ouellette AJ, Lualdi JC (1990). A novel mouse gene family coding for cationic, cysteine-rich peptides. J Biol Chem 265: 9831-9837.
53. Ouhara K, Komatsuzawa H, Yamada S et al (2005). Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, beta-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother 55: 888-896.
54. Ozturk A, Famili P, Vieira AR (2010). The antimicrobial peptide DEFB1 is associated with caries. J Dent Res 89: 631-636.
55. Pantelis A, Wenghoefer M, Haas S et al (2009). Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 45: 526-530.
56. Pingel LC, Kohlgraf KG, Hansen CJ et al (2008). Human beta-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis, and attenuates a pro-inflammatory cytokine response. Immunol Cell Biol 86: 643-649.
57. Pollard JW (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78.
58. Premratanachai P, Joly S, Johnson GK, McCray PB Jr, Jia HP, Guthmiller JM (2004). Expression and regulation of novel human beta-defensins in gingival keratinocytes. Oral Microbiol Immunol 19: 111-117.
59. Quinones-Mateu ME, Lederman MM, Feng Z et al (2003). Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. Aids 17: F39-F48.
60. Rohrl J, Yang D, Oppenheim JJ, Hehlgans T (2010). Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol 184: 6688-6694.
61. Ryan LK, Diamond G (2010). Mouse beta-defensin-1 plays a role in influenza innate immunity. J Immun 37: 49.
62. Ryan LK, Diamond G, Amrute S, Feng Z, Weinberg A, Fitzgerald-Bocarsly P (2003). Detection of HBD-1 peptide in peripheral blood mononuclear cell subpopulations by intracellular flow cytometry. Peptides 24: 1785-1794.
63. Sawaki K, Mizukawa N, Yamaai T, Fukunaga J, Sugahara T (2002). Immunohistochemical study on expression of alpha-defensin and beta-defensin-2 in human buccal epithelia with candidiasis. Oral Dis 8: 37-41.
64. Schaefer AS, Richter GM, Nothnagel M et al (2010). 3' UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun 11: 45-54.
65. Scott MG, Vreugdenhil AC, Buurman WA, Hancock RE, Gold MR (2000). Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 164: 549-553.
66. Selsted M.E., Szlarek D, Lehrer RI (1984). Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun 45: 150-154.
67. Selsted ME, Brown DM, DeLange RJ, Harwig SSL, Lehrer RI (1985). Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem 260: 4579-4585.
68. Selsted ME, Tang Y-Q, Morris WL et al (1993). Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils. J Biol Chem 268: 6641-6648.
69. Semple F, Webb S, Li HN et al (2010). Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol 40: 1073-1078.
70. Seo ES, Blaum BS, Vargues T et al (2010). Interaction of human beta-defensin 2 (HBD-2) with glycosaminoglycans. Biochemistry 49: 10486-10495.
71. Shelburne CE, Coulter WA, Olguin D, Lantz MS, Lopatin DE (2005). Induction of beta-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrob Agents Chemother 49: 183-187.
72. Shin JE, Choi Y (2010). Treponema denticola suppresses expression of human beta-defensin-2 in gingival epithelial cells through inhibition of TNFalpha production and TLR2 activation. Mol Cells 29: 407-412.
73. Shin JE, Kim YS, Oh JE, Min BM, Choi Y (2010). Treponema denticola suppresses expression of human beta-defensin-3 in gingival epithelial cells through inhibition of the toll-like receptor 2 axis. Infect Immun 78: 672-679.
74. Song W, Shi Y, Xiao M et al (2009). In vitro bactericidal activity of recombinant human beta-defensin-3 against pathogenic bacterial strains in human tooth root canal. Int J Antimicrob Agents 33: 237-243.
75. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N (2003). Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170: 5583-5589.
76. Stegemann C, Kolobov A Jr, Leonova YF et al (2009). Isolation, purification and de novo sequencing of TBD-1, the first beta-defensin from leukocytes of reptiles. Proteomics 9: 1364-1373.
77. Tugizov SM, Herrera R, Veluppillai P et al (2010). HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology 409: 211-222.
78. Valore EV, Ganz T (1992). Posttranslational processing of defensins in immature human myeloid cells. Blood 79: 1538-1544.
79. Valore EV, Martin E, Harwig SS, Ganz T (1996). Intramolecular inhibition of human defensin HNP-1 by its propiece. J Clin Invest 97: 1624-1629.
80. Veerayutthwilai O, Byers MR, Pham TT, Darveau RP, Dale BA (2007). Differential regulation of immune responses by odontoblasts. Oral Microbiol Immunol 22: 5-13.
81. Wanke I, Steffen H, Christ C et al (2010). Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol. 131: 382-390.
82. Weinberg A, Quinones-Mateu ME, Lederman MM (2006). Role of human beta-defensins in HIV infection. Adv Dent Res 19: 42-48.
83. Wenghoefer M, Pantelis A, Dommisch H et al (2008a). Nuclear hBD-1 accumulation in malignant salivary gland tumours. BMC Cancer 8: 290.
84. Wenghoefer M, Pantelis A, Dommisch H et al (2008b). Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg 37: 660-663.
85. Whittington CM, Papenfuss AT, Bansal P et al (2008a). Defensins and the convergent evolution of platypus and reptile venom genes. Genome Res 18: 986-994.
86. Whittington CM, Papenfuss AT, Kuchel PW, Belov K (2008b). Expression patterns of platypus defensin and related venom genes across a range of tissue types reveal the possibility of broader functions for OvDLPs than previously suspected. Toxicon 52: 559-565.
87. Wong JH, Xia L, Ng TB (2007). A review of defensins of diverse origins. Curr Protein Pept Sci 8: 446-459.
88. Wu Z, Hoover DM, Yang D et al (2003). Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci (USA) 100: 8880-8885.
89. Yang D, Chertov O, Bykovskaia SN et al (1999). beta-defensins: linking innate and adaptive immunity through dendritic and t cell CCR6. Science 286: 525-528.
90. Yang D, Biragyn A, Kwak LW, Oppenheim JJ (2002). Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 23: 291-296.
91. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ (2004). Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 22: 181-215.
92. Yin L, Chino T, Horst OV et al (2010). Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria. BMC Immunol 11: 37.
93. Yoshimoto T, Yamaai T, Mizukawa N et al (2003). Different expression patterns of beta-defensins in human squamous cell carcinomas. Anticancer Res 23: 4629-4633.
94. Zhu S (2007). Evidence for myxobacterial origin of eukaryotic defensins. Immunogenetics 59: 949-954.
95. Zilbauer M, Jenke A, Wenzel G et al (2010). Expression of human beta-defensins in children with chronic inflammatory bowel disease. PLoS ONE 5: e15389.